MedAlliance announces completion of enrollment in Japanese SELUTION SLR™ Study

MedAlliance, with its Japanese partner MDK Medical, has completed enrollment in the clinical study of its novel Sirolimus Drug Eluting Balloon (DEB), SELUTION SLR™, for the treatment of peripheral arterial disease (PAD). This follows the acceptance of a Clinical Trial Notification (CTN) by Japan’s Pharmaceutical and Medical Device Agency (PMDA) in June 2020. The study involves […]

thaipr.net

27 ก.ย. 64

Results from Novavax NanoFlu Influenza Vaccine Phase 3 Clinical Trial Published in The Lancet Infectious Diseases

– Pivotal Phase 3 trial achieved all primary endpoints, demonstrating non-inferiority to a leading U.S.-licensed quadrivalent influenza vaccine – NanoFlu™ vaccine candidate induced significantly enhanced cell-mediated immune responses – NanoFlu was well-tolerated with a comparable safety profile Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious…

thaipr.net

27 ก.ย. 64

Novavax and Serum Institute of India Announce Submission to World Health Organization for Emergency Use Listing of Novavax’ COVID-19 Vaccine

Novavax and Serum Institute of India file regulatory submission for World Health Organization Emergency Use Listing of Novavax’ recombinant nanoparticle protein-based COVID-19 vaccine Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, with its partner, Serum Institute of India Pvt. Ltd. (SII), today announced a regulatory […]

thaipr.net

27 ก.ย. 64
1 95 96 97 98 99 128